Research and Markets: Global Monoclonal Antibody Market Analysis

DUBLIN, Nov 12, 2010 (BUSINESS WIRE) -- Research and Markets ( has announced the addition of the "Global Monoclonal Antibody Market Analysis" report to their offering.

Considered as an indispensable tool in the clinical and biotechnology sector, monoclonal antibodies have testified to be useful in the diagnosis and treatment of many infectious, immune, and neoplastic diseases along with its application in the study of pathogen-host interactions and dialing, detection, & quantification of different molecules. The presence of monoclonal antibodies therapeutics has changed the face of modern medicine in the past decade as they provide innovative and effective therapies for numerous previously refractory illnesses. The number of monoclonal antibodies reaching the marketplace has exponentially increased over the past few years. Various factors such as rapid uptake of monoclonal antibodies, expansion of patient base due to the drug approvals received, and no generics for biological therapies have driven the optimistic market performance of this industry.

According to this new research report Global Monoclonal Antibody Market Analysis, the global monoclonal antibodies market witnessed an annual growth rate of around 13% during 2008-2009. Presently, large pharmaceutical companies are investing heavily both in developing such drugs internally and acquiring monoclonal antibody candidates from other companies. The inherent specificity and predictability of monoclonal antibodies that reduces the time period of drug development and increases rate of success in preclinical and clinical trials, relative to non-biological small molecule drugs, is further boosting the growth of the industry.

Key Topics Covered: 1. Analyst View 2. Research Methodology 3. Monoclonal Antibodies - An Introduction 4. Market Drivers 5. Industry Performance 6. Key Geographical Markets 7. Key Drugs Analysis 8. Major Acquisitions & Alliances 9. Key Players Profile List of Tables List of Figures Companies Mentioned: Roche Johnson & Johnson Abbott GSK Merck KGaA Pfizer For more information visit SOURCE: Research and Markets CONTACT: Research and Markets Laura Wood, Senior Manager, U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Copyright Business Wire 2010 -0- KEYWORD: United States

North America



Clinical Trials





General Health